Core Insights - SeoulCeuticals positions itself as a unique US-based skincare brand sourcing authentic Korean ingredients, addressing the rising consumer demand for traditional Korean heritage in beauty products [1][2]. Industry Overview - The modernization of hanbang, traditional Korean herbal medicine, is identified as the defining trend in K-beauty for 2026, merging traditional practices with modern scientific validation [2]. - The global K-beauty market reached $11.1 billion in 2025, with North America accounting for $3.1 billion, indicating significant market potential for brands like SeoulCeuticals [3]. Company Profile - Founded in 2017, SeoulCeuticals has nearly a decade of experience in sourcing and formulating products with Korean heritage ingredients, including Panax Ginseng Extract, Rice Bran, Snail Mucin, and PDRN [2][4]. - The brand emphasizes quality control by manufacturing in US facilities, ensuring faster delivery to North American customers [4]. Product Efficacy - Clinical research highlights the skin benefits of key heritage ingredients: - Panax Ginseng's ginsenosides inhibit collagen degradation - Fermented Rice Bran enhances skin barrier and provides gentle exfoliation - Snail Mucin supports collagen synthesis and fibroblast proliferation [5][12]. - The synergy of these ingredients reflects the hanbang philosophy, where each component enhances the others [6]. Product Offerings - SeoulCeuticals' Snail Mucin + Niacinamide Serum features a high concentration of Snail Mucin (97.5%) combined with other beneficial ingredients, showcasing the brand's approach to multi-active formulations [7]. - The Day Glow Serum incorporates multiple Korean-sourced actives, moving away from reliance on a single hero ingredient [7]. Expert Commentary - The brand's philosophy emphasizes prevention over treatment, with a focus on the synergistic effects of its heritage ingredients [8]. Brand Commitment - SeoulCeuticals aims to provide quality, natural beauty solutions while honoring Korean beauty traditions, offering vegan and cruelty-free formulations suitable for all skin types [9].

Core Insights - The report from CICC indicates that by 2026, the narrative in the light industry retail beauty sector will shift from "expansion" to "quality enhancement," driven by consumer demand for emotional and functional value, supply upgrades, and supportive consumption policies [1] Group 1: Demand Trends - Four key demand trends identified in the light industry retail beauty sector include: sustained emotional consumption, coexistence of rational and high-end recovery, dominance of functional demand, and continued preference for domestic brands, all influenced by demographic changes and generational shifts [1] Group 2: Supply Innovations - Three types of supply innovations are observed: creation of new categories to meet emotional needs, development of new functionalities in beauty and personal care products, and integration of new technologies such as AI in products like AI glasses and toys, representing a quality upgrade in industry supply [1] Group 3: Policy Support - Current consumption support policies aim to establish a systematic long-term mechanism, providing support and transformation across three dimensions: consumer主体, quality enhancement of consumption and service products, and optimization of consumption scenarios, with industries related to AI and elder care expected to benefit [1] Group 4: Sector Outlook for 2026 - In the beauty and medical aesthetics sector, growth is anticipated to be driven by supply-side innovations such as PDRN and functional upgrades, with domestic leading brands expected to continue gaining market share [2] - The潮玩 retail sector is projected to maintain high global demand, with leading companies innovating in product categories, deepening IP operations, and upgrading channels to create new growth opportunities, while international expansion remains strong [2] - The light manufacturing sector is expected to see weak recovery in demand but presents structural opportunities, particularly for export-oriented companies with production and brand advantages, as well as those seizing opportunities from industry transformations [2] Group 5: Investment Strategy for 2026 - Investment strategies should focus on three main lines: long-term positioning in emotional and self-consumption sectors such as潮玩, beauty and personal care, and new tobacco; attention to investment opportunities catalyzed by new technologies like AI; and proactive positioning to benefit from stimulus policies and fundamental recovery in traditional sectors [2]

Core Viewpoint - The report from CICC forecasts that by 2026, the light industry retail beauty sector will shift its narrative from "expansion" to "quality improvement," driven by consumer demand for emotional and functional value, supply upgrades, and supportive consumption policies [1] Industry Outlook Beauty and Medical Aesthetics - The growth in the beauty and medical aesthetics sector is expected to be primarily driven by supply-side innovations, such as PDRN and functional upgrades, creating structural opportunities. Domestic leading brands are anticipated to continue increasing their market share [1] Trendy Toys Retail - The trendy toy category is projected to maintain high demand globally, with leading companies expected to create new growth opportunities through continuous product innovation, deep IP operations, and channel upgrades. The trend of going overseas remains strong [1] Light Industry Manufacturing - The industry is expected to see a weak recovery in demand, but there are structural opportunities. Companies with production capacity advantages and brand strengths, particularly export-oriented firms, are favored. Additionally, companies that seize opportunities for business transformation during industry changes are expected to generate new growth momentum [1]

Core Viewpoint - The recovery of high-end consumption in China is accelerating, driven primarily by the wealth effect of high-net-worth individuals and policy stimuli targeting the middle class [1] Group 1: Duty-Free Industry - The duty-free sector is expected to benefit significantly from the recovery of high-end consumption, with a low base and strong policy incentives driving growth [2] - The launch of the Hainan Free Trade Port is anticipated to have a substantial impact on local and national duty-free businesses, with a continued trend of high-end consumption recovery [2] - China Duty Free Group is expected to see sustained performance growth, driven by both domestic demand recovery and the untapped potential of inbound tourist spending [2] Group 2: Gold and Jewelry - Rising gold prices are favorable for high-end self-consumption and brand transformation, with consumers increasingly valuing emotional connections over mere functionality [3] - The trend of store adjustments is expected to continue, with companies that expand their channels by 2026 likely to see greater performance elasticity [3] - Companies like Lao Pu Gold and Chao Hong Ji are expected to perform well due to strategic store optimization and product offerings [3] Group 3: Baijiu Industry - The baijiu industry is showing signs of recovery, with strong demand for premium products like Moutai, which has seen prices rise above 1,700 yuan per box [4] - The overall performance of the baijiu industry is expected to stabilize, with a gradual easing of price pressures and improved market conditions post-Spring Festival [4][5] Group 4: Medical Aesthetics - The medical aesthetics market is entering a new phase, driven by innovative ingredients like recombinant collagen and PDRN, which meet the growing consumer demand for regenerative and anti-aging solutions [6] - Companies with early advantages in regulatory compliance are establishing significant barriers to entry, particularly in the emerging biocompatible materials market [6] - The market dominance of these new ingredients is expected to follow a clear hierarchy, with recombinant collagen leading the way [6]

Core Insights - The PDRN market is projected to experience a 27-fold growth from 2023 to 2025, transitioning from a niche medical beauty category to a mainstream consumer product [15][19]. - The market is characterized by a significant supply-demand mismatch, with domestic brands leveraging "form innovation" to gain competitive advantages [5][35]. - The report emphasizes the importance of understanding both consumer needs and marketing claims to accurately identify genuine demand versus superficial concepts [4][6]. Market Dynamics - The PDRN market is expected to see a compound annual growth rate (CAGR) of 424.8% from 2023 to 2025, with average prices stabilizing around 220 yuan, indicating a shift towards mass-market appeal [15][18]. - Sales volume is projected to increase from 11 million units in 2023 to 183 million units by 2025, reflecting a 24-fold rise [16][18]. - The market is currently dominated by content-driven platforms, with Douyin accounting for 77.5% of sales and experiencing a CAGR of 438.4% [20][21]. Competitive Landscape - The market is shifting from oligopoly to full competition, with the top three brands' market share declining by 26.7%, allowing new entrants to gain traction [25][26]. - Domestic brands like Zhanwai Ji have captured 33.9% of the market share, while traditional Korean brands like Lijuzhuan have dropped to 1.6% [39][35]. - The report highlights the need for brands to balance high efficacy with user-friendly experiences to succeed in the evolving market [8][11]. Consumer Behavior - There is a notable consumer preference for products that offer immediate results, such as "emergency relief" solutions for issues like fatigue and skin dullness [6][10]. - The satisfaction rate for products marketed as "quick absorption" is as high as 99%, while dissatisfaction with "heavy feel" products can drop to -86% [6][11]. - The report indicates that consumers are increasingly skeptical of high-priced products without clear efficacy, leading to a demand for transparency in ingredient sourcing and product claims [58][59]. Strategic Recommendations - Brands should focus on creating products that address specific consumer pain points, such as "makeup base" and "fatigue relief," rather than relying on complex scientific narratives [6][8]. - The report suggests that the future winners will be those who can effectively communicate and deliver on practical benefits rather than abstract concepts [6][11]. - Companies are encouraged to adopt a multi-channel strategy, utilizing platforms like Douyin for initial consumer engagement and Tmall for brand loyalty and higher-value transactions [22][24].

Group 1: Medical Aesthetics Industry - The Chinese medical aesthetics market is expected to reach nearly 370 billion yuan by 2025, with a compound annual growth rate (CAGR) of approximately 10% projected until 2030, potentially reaching 600 billion yuan [2][8][36] - The trend of "self-pleasure consumption" is prominent, with about 50% of users indicating that the reason for choosing medical aesthetics is that "becoming beautiful makes them happier" [8][11][15] - The consumer demographic is shifting towards younger individuals, with the proportion of users under 25 years old increasing from 26% in 2022 to 35% by 2025 [20][22][36] - Light medical aesthetics are becoming mainstream, accounting for 52% of the market in 2022, with a growing preference for non-invasive procedures [16][17][36] - The market for recombinant collagen is expected to grow significantly, with a projected CAGR of 41.4% from 2023 to 2027, potentially reaching 114.5 billion yuan [8][45] Group 2: Beauty Industry - The retail sales of cosmetics in China are projected to grow at a CAGR of approximately 9% from 2016 to 2024, with a moderate recovery expected in 2025 [3][9] - The trend of "self-gifting" is becoming the primary scenario for beauty consumption, reflecting the strengthening of "self-pleasure consumption" [3][8] - The cosmetics raw materials market is expected to grow from 1147.8 billion yuan in 2019 to 1603.9 billion yuan by 2024, with a CAGR of 6.9% [3][9] - The ODM (Original Design Manufacturer) industry for cosmetics is projected to reach 62.29 billion yuan by 2025, with domestic brands gaining market share [3][9] Group 3: Related Companies on the Beijing Stock Exchange - Companies such as Jinbo Biological, which leads in recombinant collagen medical devices and is entering the functional skincare market, are expected to benefit from the ongoing growth in the beauty consumption sector [3][8] - Bawei Co., which provides ODM services for domestic and international cosmetic brands, is also positioned to gain from the industry's expansion [3][8] - Leading companies in cosmetic raw materials, such as Weiqi Technology and Jiakai Biological, are well-placed to capitalize on the industry's growth [3][8]

Group 1: Medical Aesthetics Industry - The Chinese medical aesthetics market is expected to reach nearly 370 billion by 2025, with a high growth outlook for the recombinant collagen segment [2][35] - The trend of younger consumers in medical aesthetics is evident, with light medical aesthetics gradually becoming mainstream, accounting for 52% of the market in 2022 [7][12] - Approximately 50.90% of users choose medical aesthetics because "becoming beautiful can make oneself happier," indicating a strong emotional value associated with beauty [4][8] Group 2: Beauty Industry - The retail sales of cosmetics in China are projected to grow at a CAGR of about 9% from 2016 to 2024, with domestic brands expected to maintain growth momentum [2][3] - The Chinese cosmetics market is entering a phase of high-quality development, with trends leaning towards scientific beauty and Eastern philosophies [3][19] - The market for cosmetic raw materials is expected to grow from 1147.80 billion in 2019 to 1603.90 billion by 2024, with a CAGR of 6.9% [2][3] Group 3: Related Companies on the Beijing Stock Exchange - Companies such as Jinbo Biological, which leads in recombinant human collagen medical devices, and Bawei Co., which provides ODM services for domestic and international cosmetic brands, are expected to benefit from the ongoing beauty consumption boom [2][3] - The market for functional skincare products is also seeing new entrants, with companies like Jinbo Biological expanding into this segment [2][3] - The beauty industry is experiencing a transformation driven by technological innovations, including synthetic biology and the application of new materials [2][3]

Investment Logic - The company is leveraging its expertise in cardiovascular devices to enter the medical aesthetics market, with a product lineup that includes facial rejuvenation injections, water light injections, PDRN, and Thermage, aiming for rapid profit growth [1] - The company employs a "rural encircling urban" strategy for channel distribution, achieving over 80% coverage in large chain medical aesthetic institutions, with plans to further penetrate second and third-tier cities [1] Product Development and Market Strategy - The facial rejuvenation injection uses materials sourced from heart stents and has quickly gained market traction, generating a tax-inclusive revenue of 100 million yuan from early August to the end of October, with expectations to rank among the top three brands in the industry [2] - PDRN is anticipated to receive domestic approval by Q1 2026, positioning the company to be the first to market with a compliant PDRN injection product in a currently underserved market [2] Financial Performance and Projections - The company's traditional business is stabilizing, while the medical aesthetics, neurostimulation, and innovative pharmaceuticals are forming new growth drivers. Revenue projections for 2025, 2026, and 2027 are 6.457 billion, 7.792 billion, and 9.243 billion yuan, respectively, with year-on-year growth rates of +5.79%, +20.68%, and +18.62% [3] - The net profit attributable to shareholders is forecasted to reach 1.048 billion, 1.285 billion, and 1.531 billion yuan for the same years, reflecting significant growth of +324.34%, +22.64%, and +19.13% [3] - The company is assigned a target price of 21 yuan based on a 30x valuation for 2026, with an initial "buy" rating [3]

Investment Rating - The report maintains a "Positive" investment rating for the beauty and personal care industry, specifically focusing on PDRN applications [6]. Core Insights - The report highlights that PDRN (Polydeoxyribonucleotide) is expected to unleash stronger commercial potential due to increasing registrations and search metrics. The extraction of PDRN is transitioning from animal sources to microbial fermentation and synthetic biology, laying a solid foundation for accelerated applications in the medical beauty and skincare sectors [3][4]. - The report emphasizes that domestic beauty companies are likely to redefine the value boundaries of PDRN, with leading firms accelerating their strategies in this competitive landscape [3][4]. Summary by Sections PDRN Overview - PDRN, derived from salmon and other sources, has a high similarity to human DNA (98%) and is known for its skin repair and cell regeneration properties. Its historical development spans from the 15th century to its current applications in medical aesthetics and cosmetics [8][13][19]. Market Growth Potential - The PDRN market is projected to grow significantly, with estimates indicating an increase from USD 0.72 billion in 2024 to USD 8.55 billion by 2031, reflecting a CAGR of 43%. The demand for anti-aging products is a core driver of this growth [8][30]. Competitive Landscape - Domestic companies are actively entering the PDRN medical and skincare sectors, with significant advancements in extraction technologies. Companies like Huaxi Biological and Lepu Medical are leading the charge in developing PDRN-based products [8][30][34]. Key Mechanisms and Benefits - PDRN operates through two main mechanisms: acting as an agonist for the adenosine A2A receptor to suppress inflammation and providing nucleotides for DNA synthesis, thus promoting cell regeneration and tissue repair [34][36]. - The primary benefits of PDRN include skin repair, anti-inflammatory effects, and anti-aging properties, making it suitable for various cosmetic and medical applications [34][39].

Core Insights - The article discusses the transformative impact of longevity science and AI on the beauty industry, emphasizing the shift in research and product development towards enhancing the quality of life rather than merely extending lifespan [5][6][10]. Group 1: Longevity Science in Beauty - Longevity science is redefining the foundational logic of beauty research, focusing on long-term skin health and preventive solutions rather than just immediate cosmetic needs [5][6]. - L'Oréal's integration of longevity science aims to transition from symptom treatment to root cause intervention, creating a comprehensive research framework that connects various aging markers to skin health [6][7]. - Companies are encouraged to develop their own longevity science theories based on their brand positioning, focusing on specific research areas like mitochondrial energy and chronic inflammation [8]. Group 2: AI's Role in Beauty Research - AI is significantly accelerating research processes in the beauty industry, with companies like L'Oréal and Unilever reporting dramatic increases in the number of molecules evaluated within shorter timeframes [11][14]. - The efficiency of AI in research is contingent upon the availability of high-quality data, necessitating the digitalization of research outcomes and the development of proprietary AI models [14]. - AI's application in ingredient discovery and development is becoming a competitive edge, with companies leveraging AI to enhance research accuracy and speed [11][14]. Group 3: PDRN and New Ingredient Trends - PDRN has emerged as a highly sought-after ingredient, with major brands like L'Oréal and Lancôme entering the market, indicating a potential surge in new product launches by 2026 [21][22]. - The development of PDRN is diversifying, with companies exploring various sources, including plant and microbial origins, to enhance efficacy and differentiate their products [22][23]. - Despite its popularity, PDRN's application in beauty products is still in its early stages, with concerns regarding its performance and safety yet to be fully validated [24]. Group 4: Advances in Peptide Technology - The beauty industry is witnessing a "technological iteration period" for recombinant collagen and functional proteins, focusing on precise structural design to address specific skin issues [25][26]. - Innovations in peptide technology include the development of multi-peptide matrices and targeted delivery systems, enhancing the effectiveness of these ingredients [26][35]. - The trend towards functionalized proteins reflects a broader industry consensus on the importance of efficacy-driven ingredient development [25][26]. Group 5: Integration of Aesthetic and Medical Approaches - The convergence of aesthetic and medical beauty is becoming a prominent trend, with brands increasingly seeking to provide scientifically validated, high-efficacy skincare solutions [30][32]. - This integration is reflected in the migration of medical-grade ingredients into consumer products, enhancing their appeal to consumers seeking immediate results [32][33]. - Brands are exploring new applications for established medical ingredients, such as PDRN and hyaluronic acid, in their product lines [32][33]. Group 6: Sensory Science and Consumer Experience - Sensory science is gaining traction in beauty research, focusing on the emotional and experiential aspects of product use, which are critical for consumer satisfaction [44][48]. - Companies are investing in technologies to quantify sensory experiences and their impact on consumer emotions, aiming to create products that resonate on a deeper level [47][48]. - The emphasis on sensory value in product development reflects a shift towards a more holistic understanding of consumer needs and preferences [44][48]. Group 7: Future Directions in Beauty Research - The article concludes that the beauty industry is entering a phase of unprecedented innovation driven by scientific advancements and consumer demand for effective, emotionally resonant products [56]. - Companies that successfully integrate rigorous scientific research with emotional engagement are likely to lead the market in the coming years [56].